Meditation for the prevention of dementia? Parkinson’s disease skin test; COVID Delirium and Cells

A meditation intervention showed positive benefits but did not significantly change the volume of the anterior cingulate cortex and insula in older people, the Age-Well trial showed. (JAMA Neurology)

Former professional rugby players had a higher risk of incident neurodegenerative disease. (Journal of Neurology, Neurosurgery and Psychiatry)

A new PET tracer designed to detect demyelination was safe and well tolerated in humans in a small study. (European Journal of Nuclear Medicine and Molecular Imaging)

Meet the super-scent that can detect Parkinson’s disease and how it led to a skin swab test to identify Parkinson’s lipid signature. (American scientist)

Blood pressure increased in migraine patients treated with gene-linked anti-calcitonin drugs (CGRP). (Neurology)

Neurogenesis was disrupted in human hippocampal progenitor cells exposed to serum samples from COVID patients with delirium, a lab study has shown. (Molecular psychiatry)

What mechanisms may contribute to neurological problems after SARS-CoV-2 infection? (neuron)

The FDA has rejected SPN-830, an investigational apomorphine infusion device designed to continuously treat motor fluctuations during “off” episodes of Parkinson’s disease, Supernus Pharmaceuticals said.

The cerebellum and cerebellar-cerebral connections were involved in emotional memories, brain imaging revealed. (PNAS)

Low-grade inflammation in midlife was an independent risk factor for poor cognitive performance later in life. (Neurology)

Is there a relationship between the number of blood leukocytes and Alzheimer’s disease? (Open JAMA Network)

  • Judy George covers neurology and neuroscience news for MedPage Today, writing about brain aging, Alzheimer’s disease, dementia, MS, rare diseases, epilepsy, autism, headaches , strokes, Parkinson’s disease, ALS, concussions, CTE, sleep, pain, etc. Follow